融創中國(01918.HK)挫12%後跌幅收窄 料去年少賺85%
融創中國(01918.HK)發盈警料去年少賺85%,該股連跌第二天兼考驗10天線(5.34元),今早曾挫12%低見5.28元獲承接,現報5.65元,續跌6%,成交1.7億股。
融創發盈警預期,截至去年底止全年溢利按年減少約85%,核心淨利潤按年下降約50%,主因是年內集團處置貝殼股票錄得投資損失、受去年下半年房地產行業嚴峻環境影響銷售收入有所減少及毛利率下降,以及計提存貨減值、應收款項等預期信貸虧損撥備有所增加所致。
集團同時公布,由於內地及香港近期爆發新一輪新冠疫情導致出行、物流及其他限制,集團料無法於本月底或之前刊發經審核全年業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.